The researchers performed a comprehensive literature search to identify published studies reporting an association between acute GVHD and genetic polymorphisms. Their study population included patients who received allogeneic HCT after myeloablative conditioning at Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance between 1992 and 2004, and included recipients with either related or unrelated donors. A genome-wide human SNP array was used with data subjected to a candidate SNP genotype determination algorithm to determine inclusion in the analysis. Of the 40 SNPs identified in the literature as gene variants potentially associated with acute GVHD, 16 could be analyzed by these methods. The researchers had previously published associations between acute GVHD risk and IL10/IL10RB SNPs, and the use of imputed genotypes to replicate this previous data was validated. Additionally, SNPs in the IL6 donor genotype was associated with a 20 to 60% increased risk for acute GVHD after transplant. Additional associations were found for SNPs in other genes, but these findings proved to be inconsistent with original publications, suggesting that the majority of published associations likely represent false-positive discoveries. This study demonstrates the advantages and disadvantages of this novel approach using SNP data in genetic analysis to study genetic associations with acute GVHD, and sets clear benchmarks for replication of genetic association studies in the stem cell transplant population.
Chien JW, Zhang XC, Fan W, Wang H, Zhao LP, Martin PJ, Storer BE, Boeckh M, Warren EH, Hansen JA. 2012. Evaluation of published single nucleotide polymorphisms associated with acute graft versus host disease. Blood; DOI:10.1182/blood-2011-09-371153.